Swiss pharma giant Roche’s first-quarter sales edge higher as its emerges from post-Covid-19 slump
Roche lowered its 2024 growth outlook in February as it continues to confront a drop-off in demand for its Covid-19
Read MoreRoche lowered its 2024 growth outlook in February as it continues to confront a drop-off in demand for its Covid-19
Read MoreBoeing has been mired in a safety crisis since a door plug blew off a 737 Max 9 in early
Read MoreTrump will receive an additional 36 million shares, worth about $1.15 billion, if the stock closes above a $17.50 minimum
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreThe billionaire investor anticipates the Middle East conflict will keep oil prices within the $80 to $90 range. Source link
Read MoreApple will launch new products on May 7 in a online event, according to invites sent to the media on
Read MoreJetBlue said second-quarter revenue would likely drop as much as 10.5% on the year. Source link
Read MoreThe chief executive of Norway's gigantic sovereign wealth fund on Tuesday said there is "clearly a lot of froth" in
Read MoreShares of Swiss drugmaker Novartis climbed as much as 4.8% in early deals Tuesday after it raised its full-year guidance
Read More